Education
About Us
Working with TipRanks
Follow Us
Australis Capital (AUSAF)
:AUSAF
AUSAF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.70
Previous CloseN/A
Volume2.50K
Average Volume (3M)9.22K
Market Cap
$5.35M
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta4441.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding293,180,540
10 Day Avg. Volume5,485
30 Day Avg. Volume9,223
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Australis Capital News
AUSAF FAQ
What was Australis Capital ’s price range in the past 12 months?
Australis Capital lowest stock price was <$0.01 and its highest was $0.70 in the past 12 months.
What is Australis Capital ’s market cap?
Australis Capital ’s market cap is $5.35M.
When is Australis Capital ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Australis Capital ’s earnings last quarter?
Currently, no data Available
Is Australis Capital overvalued?
According to Wall Street analysts Australis Capital ’s price is currently Overvalued.
Does Australis Capital pay dividends?
Australis Capital does not currently pay dividends.
What is Australis Capital ’s EPS estimate?
Australis Capital ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Australis Capital have?
Australis Capital has 293,180,540 shares outstanding.
What happened to Australis Capital ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Australis Capital ?
Currently, no hedge funds are holding shares in AUSAF
Company Description
Australis Capital
Australis Capital Inc. operates as a cannabis company. It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. The company is based in Las Vegas, Nevada.
Khiron Life Sciences
―
PharmaCielo
―
Sproutly Canada
―
CordovaCann
―
Sweet Earth Holdings
―